Does Dr. WALLACE AKERLEY have financial conflicts of interest?

Dr. WALLACE AKERLEY (MD) has received a total of $16,438 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $16,438 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. WALLACE AKERLEY?

According to CMS Open Payments data, Dr. WALLACE AKERLEY received funding from ELI LILLY AND COMPANY ($9,800), E.R. SQUIBB & SONS, L.L.C ($4,875), and BRISTOL MYERS SQUIBB COMPANY ($1,625).

Does Dr. WALLACE AKERLEY receive research grants or speaking fees?

Dr. WALLACE AKERLEY has received $16,438 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. WALLACE AKERLEY

MDReal-Time Hydrated

Specialty: Internal Medicine, Medical Oncology

Practice Location: SALT LAKE CITY, UT 84112

NPI Number: 1346330966

LIFETIME INDUSTRY VALUE

$16,438

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. AKERLEY is a verified Internal Medicine, Medical Oncology practitioner based in SALT LAKE CITY, UT.

Between 2021 and 2025, Dr. AKERLEY had an overall industry promotional and research financial footprint of $16,438 as recorded in the federal CMS Open Payments database.

$16,438 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AKERLEY's primary funding source is ELI LILLY AND COMPANY, which accounts for $9,800 (representing 59.6% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

ELI LILLY AND COMPANY

Rank 1

$9,800

59.6%

E.R. SQUIBB & SONS, L.L.C

Rank 2

$4,875

29.7%

BRISTOL MYERS SQUIBB COMPANY

Rank 3

$1,625

9.9%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.